Historical source coverage

2026, page 6

1719 selected records with a cited source date in 2026, shown 200 per page, newest first. This archive is selective and does not imply continuous monitoring or complete historical coverage.

Explore 2026 by record type

4 types

July 2026

62 records on this page

Literature metadata · MOTS-c

PubMed record PMID 41802484

PeptideScanner retained PubMed bibliographic metadata for PMID 41802484 at 2026-08-10T18:13:44.802Z. PubMed recorded a metadata revision date of 2026-07-10 and an Entrez history date of 2026-03-09. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · MOTS-c

PubMed record PMID 41811086

PeptideScanner retained PubMed bibliographic metadata for PMID 41811086 at 2026-08-10T18:13:44.817Z. PubMed recorded a metadata revision date of 2026-07-10 and an Entrez history date of 2026-03-11. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Elamipretide

PubMed record PMID 38237649

PeptideScanner retained PubMed bibliographic metadata for PMID 38237649 at 2026-08-10T18:13:32.340Z. PubMed recorded a metadata revision date of 2026-07-09 and an Entrez history date of 2024-01-18. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Vosoritide

PubMed record PMID 41762856

PeptideScanner retained PubMed bibliographic metadata for PMID 41762856 at 2026-08-10T18:13:42.759Z. PubMed recorded a metadata revision date of 2026-07-09 and an Entrez history date of 2026-02-28. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Setmelanotide

PubMed record PMID 42418774

PeptideScanner retained PubMed bibliographic metadata for PMID 42418774 at 2026-08-10T18:13:53.869Z. PubMed recorded a metadata revision date of 2026-07-09 and an Entrez history date of 2026-07-08. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Retatrutide

PubMed record PMID 42425580

PeptideScanner retained PubMed bibliographic metadata for PMID 42425580 at 2026-08-10T18:13:55.212Z. PubMed recorded a metadata revision date of 2026-07-09 and an Entrez history date of 2026-07-09. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · MOTS-c

PubMed record PMID 41706383

PeptideScanner retained PubMed bibliographic metadata for PMID 41706383 at 2026-08-10T18:13:42.683Z. PubMed recorded a metadata revision date of 2026-07-08 and an Entrez history date of 2026-02-18. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · MOTS-c

PubMed record PMID 41710402

PeptideScanner retained PubMed bibliographic metadata for PMID 41710402 at 2026-08-10T18:13:42.691Z. PubMed recorded a metadata revision date of 2026-07-08 and an Entrez history date of 2026-02-19. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · MOTS-c

PubMed record PMID 41732124

PeptideScanner retained PubMed bibliographic metadata for PMID 41732124 at 2026-08-10T18:13:42.721Z. PubMed recorded a metadata revision date of 2026-07-08 and an Entrez history date of 2026-02-24. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Abaloparatide

PubMed record PMID 41714054

PeptideScanner retained PubMed bibliographic metadata for PMID 41714054 at 2026-08-10T18:13:42.699Z. PubMed recorded a metadata revision date of 2026-07-08 and an Entrez history date of 2026-02-19. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Efpeglenatide

ClinicalTrials.gov record NCT06174779

PeptideScanner retained ClinicalTrials.gov record NCT06174779 at 2026-11-16T17:34:46.889Z. Its registry update date was 2026-07-07, and PeptideScanner's reviewed identity mapping was efpeglenatide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Oxytocin

Oxytocin for chronic pain and acupuncture analgesia.

PubMed lists PMID 41666492 in Current opinion in pharmacology as Journal Article, Review, with publication-date metadata of 2026-01-20 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Vasopressin

Acquired transient vasopressin deficiency by cannabinoids and other substances.

PubMed lists PMID 41668460 in Endocrinology as Journal Article, Review, with publication-date metadata of 2026-03-06 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Glucagon

Clinical Pharmacology of Glucagon.

PubMed lists PMID 38847591 in Clinical pharmacology and therapeutics as Journal Article, Review, with publication-date metadata of 2024-06-07 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Liraglutide

Liraglutide and systolic blood pressure.

PubMed lists PMID 30515941 in Journal of clinical hypertension (Greenwich, Conn.) as Letter, with publication-date metadata of 2018-12-05 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · MOTS-c

PubMed record PMID 41654147

PeptideScanner retained PubMed bibliographic metadata for PMID 41654147 at 2026-08-10T18:13:40.626Z. PubMed recorded a metadata revision date of 2026-07-07 and an Entrez history date of 2026-02-07. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Elamipretide

PubMed record PMID 42415111

PeptideScanner retained PubMed bibliographic metadata for PMID 42415111 at 2026-08-10T18:13:53.859Z. PubMed recorded a metadata revision date of 2026-07-07 and an Entrez history date of 2026-07-07. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Abaloparatide

PubMed record PMID 39789749

PeptideScanner retained PubMed bibliographic metadata for PMID 39789749 at 2026-08-10T18:13:36.068Z. PubMed recorded a metadata revision date of 2026-07-07 and an Entrez history date of 2025-01-10. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Regulatory · Vasopressin

Federal Register notice 2026-13492

The Federal Register published notice 2026-13492, attributed to FDA and its parent HHS department, on 2026-07-06. Its official title is “Determination That VASOPRESSIN IN SODIUM CHLORIDE (vasopressin) 0.9%, Injection, 50 units/50 milliliters (1 unit/milliliters) Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Vasopressin.

Source: Federal Register via GovInfo ↗

→

Literature metadata · Tirzepatide

Tirzepatide, the Newest Medication for Type 2 Diabetes: A Review of the Literature and Implications for Clinical Practice.

PubMed lists PMID 38247052 in The Annals of pharmacotherapy as Review, Letter, with publication-date metadata of 2024-01-21 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Tirzepatide

Correction: Clinical Implications of Mounjaro (Tirzepatide) for Breast Cancer Detection and Management: A Narrative Review.

PubMed lists PMID 42388932 in Cureus as Published Erratum, Journal Article, with publication-date metadata of 2026-06-30 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Vosoritide

PubMed record PMID 41621839

PeptideScanner retained PubMed bibliographic metadata for PMID 41621839 at 2026-08-10T18:13:40.584Z. PubMed recorded a metadata revision date of 2026-07-06 and an Entrez history date of 2026-02-01. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Setmelanotide

PubMed record PMID 42205046

PeptideScanner retained PubMed bibliographic metadata for PMID 42205046 at 2026-08-10T18:13:50.682Z. PubMed recorded a metadata revision date of 2026-07-06 and an Entrez history date of 2026-05-28. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Dulaglutide

PubMed record PMID 37743669

PeptideScanner retained PubMed bibliographic metadata for PMID 37743669 at 2026-08-10T18:13:32.327Z. PubMed recorded a metadata revision date of 2026-07-06 and an Entrez history date of 2023-09-25. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Liraglutide

Glycemia and Gluconeogenesis With Metformin and Liraglutide: A Randomized Trial in Youth-onset Type 2 Diabetes.

PubMed lists PMID 37967247 in The Journal of clinical endocrinology and metabolism as Randomized Controlled Trial, Journal Article, with publication-date metadata of 2024-04-19 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Pramlintide

PubMed record PMID 41174925

PeptideScanner retained PubMed bibliographic metadata for PMID 41174925 at 2026-08-10T18:13:37.974Z. PubMed recorded a metadata revision date of 2026-07-05 and an Entrez history date of 2025-11-01. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Setmelanotide

PubMed record PMID 38567654

PeptideScanner retained PubMed bibliographic metadata for PMID 38567654 at 2026-08-10T18:13:32.350Z. PubMed recorded a metadata revision date of 2026-07-04 and an Entrez history date of 2024-04-03. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Maridebart cafraglutide

ClinicalTrials.gov record NCT07037459

PeptideScanner retained ClinicalTrials.gov record NCT07037459 at 2026-08-10T18:10:04.222Z. Its registry update date was 2026-07-02, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Tirzepatide

Can tirzepatide untie the Gordian knot of eating disorders among individuals with type 2 diabetes and obesity?

PubMed lists PMID 39018899 in Journal of diabetes and its complications as Editorial, with publication-date metadata of 2024-07-15 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Vosoritide

PubMed record PMID 38649657

PeptideScanner retained PubMed bibliographic metadata for PMID 38649657 at 2026-08-10T18:13:32.355Z. PubMed recorded a metadata revision date of 2026-07-02 and an Entrez history date of 2024-04-22. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Lixisenatide

PubMed record PMID 38870730

PeptideScanner retained PubMed bibliographic metadata for PMID 38870730 at 2026-08-10T18:13:32.367Z. PubMed recorded a metadata revision date of 2026-07-02 and an Entrez history date of 2024-06-13. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Glucagon

Insulin and glucagon ratio in the patho-physiology of diabetic ketoacidosis and hyperosmolar hyperglycemic non-ketotic diabetes.

PubMed lists PMID 16441980 in Journal of the College of Physicians and Surgeons--Pakistan : JCPSP as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2006-01 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Semaglutide

Semaglutide in Schizophrenia-A Top Clinical Trial.

PubMed lists PMID 42384388 in JAMA psychiatry as Journal Article, with publication-date metadata of 2026-07-01 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Teriparatide

Bioequivalence of Recombinant Human Teriparatide Injection in Healthy Adult Female Subjects in the Fasting State.

PubMed lists PMID 38923284 in Clinical pharmacology in drug development as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-06-24 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Liraglutide

Oral delivery of liraglutide using CPP/hyaluronic acid-modified mesoporous silica nanoparticles: A virus-inspired strategy for intestinal absorption.

PubMed lists PMID 41604908 in Biomaterials advances as Journal Article, with publication-date metadata of 2026-01-14 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Elamipretide

PubMed record PMID 38602181

PeptideScanner retained PubMed bibliographic metadata for PMID 38602181 at 2026-07-30T16:11:44.832Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2024-04-11. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Linaclotide

PubMed record PMID 39370607

PeptideScanner retained PubMed bibliographic metadata for PMID 39370607 at 2026-07-30T16:11:44.834Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2024-10-07. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Elamipretide

PubMed record PMID 41596703

PeptideScanner retained PubMed bibliographic metadata for PMID 41596703 at 2026-07-30T16:11:44.884Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2026-01-28. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Exenatide

PubMed record PMID 41597428

PeptideScanner retained PubMed bibliographic metadata for PMID 41597428 at 2026-07-30T16:11:44.888Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2026-01-28. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Vosoritide

PubMed record PMID 41610120

PeptideScanner retained PubMed bibliographic metadata for PMID 41610120 at 2026-07-30T16:11:44.897Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2026-01-29. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Abaloparatide

PubMed record PMID 41579168

PeptideScanner retained PubMed bibliographic metadata for PMID 41579168 at 2026-07-30T16:11:44.866Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2026-01-24. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · BPC-157

PubMed record PMID 42385164

PeptideScanner retained PubMed bibliographic metadata for PMID 42385164 at 2026-07-30T16:11:44.943Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2026-07-01. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Liraglutide

PubMed record PMID 42385677

PeptideScanner retained PubMed bibliographic metadata for PMID 42385677 at 2026-07-30T16:11:44.943Z. PubMed recorded a metadata revision date of 2026-07-01 and an Entrez history date of 2026-07-01. PeptideScanner associated this retained record with the identity slug liraglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

June 2026

138 records on this page

Clinical trials · Orforglipron

ClinicalTrials.gov record NCT06010004

PeptideScanner retained ClinicalTrials.gov record NCT06010004 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-06-30, and PeptideScanner's reviewed identity mapping was orforglipron.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Icatibant

Icatibant for acute hereditary angioedema attacks in pediatric patients: A systematized review.

PubMed lists PMID 42343494 in Allergy and asthma proceedings as Journal Article, Systematic Review, with publication-date metadata of 2026-07-01 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Liraglutide

Liraglutide for idiopathic intracranial hypertension: a real-world propensity score-matched study.

PubMed lists PMID 39949066 in Annals of clinical and translational neurology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-02-13 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Vosoritide

PubMed record PMID 39305160

PeptideScanner retained PubMed bibliographic metadata for PMID 39305160 at 2026-07-30T16:14:08.845Z. PubMed recorded a metadata revision date of 2026-06-30 and an Entrez history date of 2024-09-21. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Cagrilintide

ClinicalTrials.gov record NCT07220642

PeptideScanner retained ClinicalTrials.gov record NCT07220642 at 2026-07-30T16:19:03.066Z. Its registry update date was 2026-06-30, and PeptideScanner's reviewed identity mapping was cagrilintide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Setmelanotide

ClinicalTrials.gov record NCT07674290

PeptideScanner retained ClinicalTrials.gov record NCT07674290 at 2026-07-30T16:19:03.062Z. Its registry update date was 2026-06-29, and PeptideScanner's reviewed identity mapping was setmelanotide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Semaglutide

Balancing oral sequential absorption barriers of semaglutide-loaded nanoparticles by optimization of surface glycocholic acid density.

PubMed lists PMID 41083011 in Journal of controlled release : official journal of the Controlled Release Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-10-11 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Semaglutide

Thermally Stressed Solid-State Stability of Semaglutide: Understanding the Influence of Temperature on Protein Content, Secondary Structure, Phase Transition, and Chemical Degradation.

PubMed lists PMID 42086873 in Pharmaceutical research as Journal Article, with publication-date metadata of 2026-05-05 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Tirzepatide

Can the NHS afford Mounjaro? It spent £574m on the jab last year despite most eligible patients not getting it.

PubMed lists PMID 42373101 in BMJ (Clinical research ed.) as Journal Article, with publication-date metadata of 2026-06-28 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · GHK-Cu

PubMed record PMID 42245779

PeptideScanner retained PubMed bibliographic metadata for PMID 42245779 at 2026-07-30T16:14:18.092Z. PubMed recorded a metadata revision date of 2026-06-29 and an Entrez history date of 2026-06-05. PeptideScanner associated this retained record with the identity slug ghk-cu. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Kisspeptin-10

Kisspeptin-10 Preserves the Blood-Brain Barrier's Integrity Post-Stroke by Augmenting Claudin-10 Expression.

PubMed lists PMID 41022671 in Clinical and experimental pharmacology & physiology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-11 (month precision). PeptideScanner associated the retained record with the identity slug kisspeptin-10. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Octreotide

Octreotide and Octreotide-derived delivery systems.

PubMed lists PMID 37211679 in Journal of drug targeting as Journal Article, Review, with publication-date metadata of 2023-05-23 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Glucagon

An integrative view on glucagon function and putative role in the progression of pancreatic neuroendocrine tumours (pNETs) and hepatocellular carcinomas (HCC).

PubMed lists PMID 37678603 in Molecular and cellular endocrinology as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-09-07 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Semaglutide

Semaglutide use in patients undergoing atrial fibrillation ablation and recurrent arrhythmia: A focused time-to-event meta-analysis.

PubMed lists PMID 42217600 in Heart rhythm as Journal Article, with publication-date metadata of 2026-05-30 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Semaglutide

Secondary alopecia due to semaglutide.

PubMed lists PMID 42364353 in Medicina clinica as Letter, with publication-date metadata of 2026-06-27 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Liraglutide

A comprehensive analysis of community pharmacists' practices, barriers, and strategies in patient education on Saxenda®: a qualitative study.

PubMed lists PMID 42015323 in Journal of pharmaceutical health care and sciences as Journal Article, with publication-date metadata of 2026-04-21 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Elamipretide

PubMed record PMID 38688894

PeptideScanner retained PubMed bibliographic metadata for PMID 38688894 at 2026-07-30T16:14:06.935Z. PubMed recorded a metadata revision date of 2026-06-27 and an Entrez history date of 2024-04-30. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Elamipretide

PubMed record PMID 41612464

PeptideScanner retained PubMed bibliographic metadata for PMID 41612464 at 2026-07-30T16:14:14.832Z. PubMed recorded a metadata revision date of 2026-06-27 and an Entrez history date of 2026-01-30. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · MOTS-c

PubMed record PMID 41680431

PeptideScanner retained PubMed bibliographic metadata for PMID 41680431 at 2026-07-30T16:14:14.846Z. PubMed recorded a metadata revision date of 2026-06-27 and an Entrez history date of 2026-02-12. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Lanreotide

PubMed record PMID 41880072

PeptideScanner retained PubMed bibliographic metadata for PMID 41880072 at 2026-07-30T16:14:14.928Z. PubMed recorded a metadata revision date of 2026-06-27 and an Entrez history date of 2026-03-25. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Abaloparatide

PubMed record PMID 42033613

PeptideScanner retained PubMed bibliographic metadata for PMID 42033613 at 2026-07-30T16:14:16.695Z. PubMed recorded a metadata revision date of 2026-06-27 and an Entrez history date of 2026-04-25. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Pegcetacoplan

ClinicalTrials.gov record NCT04901936

PeptideScanner retained ClinicalTrials.gov record NCT04901936 at 2026-11-16T01:37:14.654Z. Its registry update date was 2026-06-26, and PeptideScanner's reviewed identity mapping was pegcetacoplan.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Vasopressin

Pediatric Central Diabetes Insipidus due to Arginine Vasopressin Deficiency in the Perianesthetic Period.

PubMed lists PMID 41552892 in Paediatric anaesthesia as Journal Article, Review, with publication-date metadata of 2026-01-19 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Regulatory · Liraglutide + 2 more

Federal Register notice 2026-12937

The Federal Register published notice 2026-12937, attributed to FDA and its parent HHS department, on 2026-06-26. Its official title is “List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Extension of Comment Period,” and PeptideScanner's exact reviewed identity mapping connects the document to Liraglutide, Semaglutide and Tirzepatide.

Source: Federal Register via GovInfo ↗

→

Literature metadata · Semaglutide

Ileum targeted semaglutide delivery and pharmacokinetic study in an experimental porcine animal model via oesophagogastroduodenoscopic administration.

PubMed lists PMID 40850442 in Journal of controlled release : official journal of the Controlled Release Society as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-08-22 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Semaglutide

Real-world healthcare resource utilization and medical costs in patients with overweight or obesity and multimorbidity treated with semaglutide in the United States.

PubMed lists PMID 41524543 in Expert review of pharmacoeconomics & outcomes research as Journal Article, Observational Study, with publication-date metadata of 2026-01-12 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Tirzepatide

Treatment Preferences For Comorbid Obesity and Obstructive Sleep Apnea (PRO-CON OSA) Survey: Patient and Provider Preferences for CPAP and/or Tirzepatide.

PubMed lists PMID 41256163 in medRxiv : the preprint server for health sciences as Journal Article, Preprint, with publication-date metadata of 2025-10-05 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Tirzepatide

Correction: Treatment preferences for comorbid obesity and obstructive sleep apnea (PRO-CON OSA) survey: Patient and provider preferences for CPAP and/or tirzepatide.

PubMed lists PMID 42151574 in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine as Published Erratum, with publication-date metadata of 2026-05-18 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Linaclotide

PubMed record PMID 38533633

PeptideScanner retained PubMed bibliographic metadata for PMID 38533633 at 2026-07-30T16:14:06.902Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2024-03-27. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · BPC-157

PubMed record PMID 40789979

PeptideScanner retained PubMed bibliographic metadata for PMID 40789979 at 2026-07-30T16:14:11.079Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2025-08-11. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Abaloparatide

PubMed record PMID 41023931

PeptideScanner retained PubMed bibliographic metadata for PMID 41023931 at 2026-07-30T16:14:12.886Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2025-09-30. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · MOTS-c

PubMed record PMID 41520850

PeptideScanner retained PubMed bibliographic metadata for PMID 41520850 at 2026-07-30T16:14:14.728Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2026-01-11. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Linaclotide

PubMed record PMID 41539984

PeptideScanner retained PubMed bibliographic metadata for PMID 41539984 at 2026-07-30T16:14:14.760Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2026-01-15. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Afamelanotide

PubMed record PMID 41547183

PeptideScanner retained PubMed bibliographic metadata for PMID 41547183 at 2026-07-30T16:14:14.777Z. PubMed recorded a metadata revision date of 2026-06-26 and an Entrez history date of 2026-01-17. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Cagrilintide

ClinicalTrials.gov record NCT07607587

PeptideScanner retained ClinicalTrials.gov record NCT07607587 at 2026-07-30T16:19:03.059Z. Its registry update date was 2026-06-25, and PeptideScanner's reviewed identity mapping was cagrilintide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Glucagon

Emerging Therapies in Metabolic Health: A Comprehensive Review of GLP-1, GIP, and Glucagon Agonists.

PubMed lists PMID 41518129 in Journal of peptide science : an official publication of the European Peptide Society as Journal Article, Review, with publication-date metadata of 2026-02 (month precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Exenatide

PubMed record PMID 39919773

PeptideScanner retained PubMed bibliographic metadata for PMID 39919773 at 2026-07-30T16:14:10.828Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2025-02-07. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Elamipretide

PubMed record PMID 41500837

PeptideScanner retained PubMed bibliographic metadata for PMID 41500837 at 2026-07-30T16:14:13.067Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2026-01-07. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Abaloparatide

PubMed record PMID 41506099

PeptideScanner retained PubMed bibliographic metadata for PMID 41506099 at 2026-07-30T16:14:13.082Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2026-01-08. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Exenatide

PubMed record PMID 42330995

PeptideScanner retained PubMed bibliographic metadata for PMID 42330995 at 2026-07-30T16:14:19.343Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2026-06-22. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Cagrilintide

PubMed record PMID 39868309

PeptideScanner retained PubMed bibliographic metadata for PMID 39868309 at 2026-07-30T16:14:10.807Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2025-01-27. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Cagrilintide

PubMed record PMID 42260118

PeptideScanner retained PubMed bibliographic metadata for PMID 42260118 at 2026-07-30T16:14:18.129Z. PubMed recorded a metadata revision date of 2026-06-25 and an Entrez history date of 2026-06-08. PeptideScanner associated this retained record with the identity slug cagrilintide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT06016855

PeptideScanner retained ClinicalTrials.gov record NCT06016855 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-06-24, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Eloralintide

ClinicalTrials.gov record NCT06230523

PeptideScanner retained ClinicalTrials.gov record NCT06230523 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-06-24, and PeptideScanner's reviewed identity mapping was eloralintide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Tirzepatide

Experience with Tirzepatide and Weight Management During and After a Clinical Trial in Japanese Patients with Obesity Disease: A Qualitative Study.

PubMed lists PMID 42334799 in Advances in therapy as Journal Article, with publication-date metadata of 2026-06-23 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Linaclotide

PubMed record PMID 39527338

PeptideScanner retained PubMed bibliographic metadata for PMID 39527338 at 2026-07-30T16:14:08.881Z. PubMed recorded a metadata revision date of 2026-06-23 and an Entrez history date of 2024-11-11. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Tirzepatide

Residual gastric content after tirzepatide discontinuation: is one week enough?

PubMed lists PMID 42329593 in Minerva anestesiologica as Journal Article, with publication-date metadata of 2026-06-22 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Dulaglutide

PubMed record PMID 38954432

PeptideScanner retained PubMed bibliographic metadata for PMID 38954432 at 2026-07-30T16:14:08.766Z. PubMed recorded a metadata revision date of 2026-06-22 and an Entrez history date of 2024-07-02. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · MOTS-c

PubMed record PMID 40035775

PeptideScanner retained PubMed bibliographic metadata for PMID 40035775 at 2026-07-30T16:14:10.913Z. PubMed recorded a metadata revision date of 2026-06-22 and an Entrez history date of 2025-03-04. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · MOTS-c

PubMed record PMID 40072017

PeptideScanner retained PubMed bibliographic metadata for PMID 40072017 at 2026-07-30T16:14:10.926Z. PubMed recorded a metadata revision date of 2026-06-22 and an Entrez history date of 2025-03-12. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Setmelanotide

PubMed record PMID 42329358

PeptideScanner retained PubMed bibliographic metadata for PMID 42329358 at 2026-07-30T16:14:19.342Z. PubMed recorded a metadata revision date of 2026-06-22 and an Entrez history date of 2026-06-22. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Vasopressin

Role of oxytocin and vasopressin in alcohol use disorder.

PubMed lists PMID 39523056 in International review of neurobiology as Journal Article, Review, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural, with publication-date metadata of 2024-10-08 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Exenatide

PubMed record PMID 40246242

PeptideScanner retained PubMed bibliographic metadata for PMID 40246242 at 2026-07-30T16:14:10.971Z. PubMed recorded a metadata revision date of 2026-06-21 and an Entrez history date of 2025-04-17. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · MOTS-c

PubMed record PMID 42324588

PeptideScanner retained PubMed bibliographic metadata for PMID 42324588 at 2026-07-30T16:14:19.320Z. PubMed recorded a metadata revision date of 2026-06-21 and an Entrez history date of 2026-06-21. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Dulaglutide

PubMed record PMID 39718468

PeptideScanner retained PubMed bibliographic metadata for PMID 39718468 at 2026-07-30T16:14:08.915Z. PubMed recorded a metadata revision date of 2026-06-20 and an Entrez history date of 2024-12-24. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Dulaglutide

PubMed record PMID 38600796

PeptideScanner retained PubMed bibliographic metadata for PMID 38600796 at 2026-07-30T16:14:06.917Z. PubMed recorded a metadata revision date of 2026-06-19 and an Entrez history date of 2024-04-11. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Abaloparatide

PubMed record PMID 40890141

PeptideScanner retained PubMed bibliographic metadata for PMID 40890141 at 2026-07-30T16:14:11.108Z. PubMed recorded a metadata revision date of 2026-06-19 and an Entrez history date of 2025-09-01. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Thymosin alpha-1

ClinicalTrials.gov record NCT06024356

PeptideScanner retained ClinicalTrials.gov record NCT06024356 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-06-18, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Dulaglutide

PubMed record PMID 38715179

PeptideScanner retained PubMed bibliographic metadata for PMID 38715179 at 2026-07-30T16:14:06.944Z. PubMed recorded a metadata revision date of 2026-06-18 and an Entrez history date of 2024-05-07. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Lixisenatide

PubMed record PMID 38685598

PeptideScanner retained PubMed bibliographic metadata for PMID 38685598 at 2026-07-30T16:14:06.932Z. PubMed recorded a metadata revision date of 2026-06-18 and an Entrez history date of 2024-04-30. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Maridebart cafraglutide

ClinicalTrials.gov record NCT07441252

PeptideScanner retained ClinicalTrials.gov record NCT07441252 at 2026-07-30T16:19:03.063Z. Its registry update date was 2026-06-18, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Liraglutide

Total and H-specific growth/differentiation factor 15 levels are unaffected by liraglutide or naltrexone/bupropion administration.

PubMed lists PMID 38757729 in Diabetes, obesity & metabolism as Journal Article, Clinical Trial, with publication-date metadata of 2024-05-17 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Elamipretide

PubMed record PMID 40570323

PeptideScanner retained PubMed bibliographic metadata for PMID 40570323 at 2026-07-30T16:14:11.030Z. PubMed recorded a metadata revision date of 2026-06-17 and an Entrez history date of 2025-06-26. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Thymosin beta-4

Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids.

PubMed lists PMID 40816274 in Stem cell reports as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-08-14 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Leuprolide

Development and Validation of a Stability-Indicating RS HPLC Method for Leuprolide Acetate and Its Related Substances: Characterization of Degradation Products With LC-MS.

PubMed lists PMID 42299119 in Biomedical chromatography : BMC as Journal Article, with publication-date metadata of 2026-07 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Linaclotide

PubMed record PMID 38869953

PeptideScanner retained PubMed bibliographic metadata for PMID 38869953 at 2026-07-30T16:14:08.743Z. PubMed recorded a metadata revision date of 2026-06-16 and an Entrez history date of 2024-06-13. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT06326190

PeptideScanner retained ClinicalTrials.gov record NCT06326190 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-06-15, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Ziconotide

PubMed record PMID 41910723

PeptideScanner retained PubMed bibliographic metadata for PMID 41910723 at 2026-07-30T16:14:16.607Z. PubMed recorded a metadata revision date of 2026-06-15 and an Entrez history date of 2026-03-30. PeptideScanner associated this retained record with the identity slug ziconotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Elamipretide

PubMed record PMID 42290373

PeptideScanner retained PubMed bibliographic metadata for PMID 42290373 at 2026-07-30T16:14:18.165Z. PubMed recorded a metadata revision date of 2026-06-15 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Elamipretide

PubMed record PMID 42291734

PeptideScanner retained PubMed bibliographic metadata for PMID 42291734 at 2026-07-30T16:14:19.224Z. PubMed recorded a metadata revision date of 2026-06-15 and an Entrez history date of 2026-06-15. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Trofinetide

Rett syndrome and real-world treatment patterns of trofinetide in the United States.

PubMed lists PMID 42287113 in Journal of medical economics as Journal Article, with publication-date metadata of 2026-06-13 (day precision). PeptideScanner associated the retained record with the identity slug trofinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Epitalon

PubMed record PMID 40493162

PeptideScanner retained PubMed bibliographic metadata for PMID 40493162 at 2026-07-30T16:14:11.014Z. PubMed recorded a metadata revision date of 2026-06-13 and an Entrez history date of 2025-06-10. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Setmelanotide

PubMed record PMID 42070740

PeptideScanner retained PubMed bibliographic metadata for PMID 42070740 at 2026-07-30T16:14:16.709Z. PubMed recorded a metadata revision date of 2026-06-13 and an Entrez history date of 2026-05-03. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Elamipretide

PubMed record PMID 42082001

PeptideScanner retained PubMed bibliographic metadata for PMID 42082001 at 2026-07-30T16:14:16.712Z. PubMed recorded a metadata revision date of 2026-06-12 and an Entrez history date of 2026-05-04. PeptideScanner associated this retained record with the identity slug elamipretide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · MOTS-c

PubMed record PMID 42142418

PeptideScanner retained PubMed bibliographic metadata for PMID 42142418 at 2026-07-30T16:14:16.748Z. PubMed recorded a metadata revision date of 2026-06-12 and an Entrez history date of 2026-05-16. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Dulaglutide

PubMed record PMID 42239562

PeptideScanner retained PubMed bibliographic metadata for PMID 42239562 at 2026-07-30T16:14:18.074Z. PubMed recorded a metadata revision date of 2026-06-12 and an Entrez history date of 2026-06-04. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Maridebart cafraglutide

ClinicalTrials.gov record NCT07226765

PeptideScanner retained ClinicalTrials.gov record NCT07226765 at 2026-07-30T16:19:03.046Z. Its registry update date was 2026-06-12, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Maridebart cafraglutide

ClinicalTrials.gov record NCT07225686

PeptideScanner retained ClinicalTrials.gov record NCT07225686 at 2026-07-30T16:19:03.064Z. Its registry update date was 2026-06-12, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Teriparatide

Bonegraft Using Octacalcium Phosphate Collagen Composite with Teriparatide and Polylactic Acid Cage.

PubMed lists PMID 41311271 in Tissue engineering. Part A as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-02-16 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Exenatide

PubMed record PMID 39805462

PeptideScanner retained PubMed bibliographic metadata for PMID 39805462 at 2026-07-30T16:14:08.923Z. PubMed recorded a metadata revision date of 2026-06-10 and an Entrez history date of 2025-01-13. PeptideScanner associated this retained record with the identity slug exenatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · MOTS-c

PubMed record PMID 42266945

PeptideScanner retained PubMed bibliographic metadata for PMID 42266945 at 2026-07-30T16:14:18.139Z. PubMed recorded a metadata revision date of 2026-06-10 and an Entrez history date of 2026-06-10. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Lanreotide

PubMed record PMID 39933708

PeptideScanner retained PubMed bibliographic metadata for PMID 39933708 at 2026-07-30T16:14:10.854Z. PubMed recorded a metadata revision date of 2026-06-09 and an Entrez history date of 2025-02-11. PeptideScanner associated this retained record with the identity slug lanreotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Vosoritide

PubMed record PMID 40099812

PeptideScanner retained PubMed bibliographic metadata for PMID 40099812 at 2026-07-30T16:14:10.937Z. PubMed recorded a metadata revision date of 2026-06-09 and an Entrez history date of 2025-03-18. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · MOTS-c

PubMed record PMID 40246631

PeptideScanner retained PubMed bibliographic metadata for PMID 40246631 at 2026-07-30T16:14:10.971Z. PubMed recorded a metadata revision date of 2026-06-09 and an Entrez history date of 2025-04-17. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Retatrutide

PubMed record PMID 42264536

PeptideScanner retained PubMed bibliographic metadata for PMID 42264536 at 2026-07-30T16:14:18.135Z. PubMed recorded a metadata revision date of 2026-06-09 and an Entrez history date of 2026-06-09. PeptideScanner associated this retained record with the identity slug retatrutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Setmelanotide

PubMed record PMID 34561620

PeptideScanner retained PubMed bibliographic metadata for PMID 34561620 at 2026-07-30T16:14:06.776Z. PubMed recorded a metadata revision date of 2026-06-08 and an Entrez history date of 2021-09-25. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Setmelanotide

PubMed record PMID 41866701

PeptideScanner retained PubMed bibliographic metadata for PMID 41866701 at 2026-07-30T16:14:14.923Z. PubMed recorded a metadata revision date of 2026-06-08 and an Entrez history date of 2026-03-23. PeptideScanner associated this retained record with the identity slug setmelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Abaloparatide

ClinicalTrials.gov record NCT04467983

PeptideScanner retained ClinicalTrials.gov record NCT04467983 at 2026-07-30T16:19:03.055Z. Its registry update date was 2026-06-08, and PeptideScanner's reviewed identity mapping was abaloparatide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Cerebrolysin

The possible role of cerebrolysin in the management of vascular dementia: Leveraging concepts.

PubMed lists PMID 39832667 in Neuroscience as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-01-19 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Vosoritide

PubMed record PMID 39740666

PeptideScanner retained PubMed bibliographic metadata for PMID 39740666 at 2026-07-30T16:14:08.917Z. PubMed recorded a metadata revision date of 2026-06-07 and an Entrez history date of 2024-12-31. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Tirzepatide

Early cardiovascular-kidney-metabolic progression with tirzepatide: population definition and clinical interpretation.

PubMed lists PMID 42155604 in Diabetes research and clinical practice as Letter, with publication-date metadata of 2026-05-19 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT04529044

PeptideScanner retained ClinicalTrials.gov record NCT04529044 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-06-05, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Linaclotide

PubMed record PMID 41413756

PeptideScanner retained PubMed bibliographic metadata for PMID 41413756 at 2026-07-30T16:14:13.037Z. PubMed recorded a metadata revision date of 2026-06-05 and an Entrez history date of 2025-12-18. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Abaloparatide

ClinicalTrials.gov record NCT04167163

PeptideScanner retained ClinicalTrials.gov record NCT04167163 at 2026-07-30T16:19:03.051Z. Its registry update date was 2026-06-05, and PeptideScanner's reviewed identity mapping was abaloparatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT04954820

PeptideScanner retained ClinicalTrials.gov record NCT04954820 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-06-04, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Trofinetide

Trofinetide treatment for Rett syndrome: Lessons to learn.

PubMed lists PMID 39395401 in Med (New York, N.Y.) as Journal Article, Comment, with publication-date metadata of 2024-10-11 (day precision). PeptideScanner associated the retained record with the identity slug trofinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Liraglutide

Approaching therapy of Alzheimer's disease via the antidiabetic drug liraglutide-a study with streptozotocin intracerebroventricularly treated Wistar rats.

PubMed lists PMID 40646278 in Journal of neural transmission (Vienna, Austria : 1996) as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2025-07-12 (day precision). PeptideScanner associated the retained record with the identity slug liraglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Pramlintide

PubMed record PMID 39109464

PeptideScanner retained PubMed bibliographic metadata for PMID 39109464 at 2026-07-30T16:14:08.819Z. PubMed recorded a metadata revision date of 2026-06-04 and an Entrez history date of 2024-08-07. PeptideScanner associated this retained record with the identity slug pramlintide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · MOTS-c

PubMed record PMID 42228044

PeptideScanner retained PubMed bibliographic metadata for PMID 42228044 at 2026-07-30T16:14:18.046Z. PubMed recorded a metadata revision date of 2026-06-04 and an Entrez history date of 2026-06-02. PeptideScanner associated this retained record with the identity slug mots-c. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Vosoritide

PubMed record PMID 42238253

PeptideScanner retained PubMed bibliographic metadata for PMID 42238253 at 2026-07-30T16:14:18.068Z. PubMed recorded a metadata revision date of 2026-06-04 and an Entrez history date of 2026-06-04. PeptideScanner associated this retained record with the identity slug vosoritide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Regulatory · Vasopressin

Federal Register notice 2026-11062

The Federal Register published notice 2026-11062, attributed to FDA and its parent HHS department, on 2026-06-03. Its official title is “Elite Laboratories, Inc. et al.; Withdrawal of Approval of 16 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Vasopressin.

Source: Federal Register via GovInfo ↗

→

Literature metadata · Pasireotide

Predictive factors and the management of hyperglycemia in patients with acromegaly and Cushing's disease receiving pasireotide treatment: post hoc analyses from the SOM230B2219 study.

PubMed lists PMID 38577574 in Frontiers in endocrinology as Clinical Trial, Phase IV, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2024-03-21 (day precision). PeptideScanner associated the retained record with the identity slug pasireotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→